Analysts expect Maxcyte, Inc. to report revenue of 6.90 M for Q3 26, against a range of 6.29 M to 7.50 M. The most recent reported quarter, Q2 26, came in at 7.27 M, a 15.2% beat against the 6.31 M consensus.
| Metric | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 | Q1 30 | Q2 30 | Q3 30 | Q4 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | 8.16 M | 8.69 M | 10.39 M | 8.20 M | 6.83 M | 7.30 M | 9.65 M | 7.27 M | - | - | - | - | - | - | - | - | ||||||||||
| High Estimate | 7.30 M | 9.01 M | 9.52 M | 10.46 M | 7.49 M | 9.15 M | 8.28 M | 6.52 M | 7.50 M | 8.48 M | 7.86 M | 9.79 M | 9.04 M | 9.35 M | 10.32 M | 9.79 M | ||||||||||
| Low Estimate | 6.78 M | 7.55 M | 7.86 M | 9.67 M | 6.76 M | 8.22 M | 7.18 M | 6.10 M | 6.29 M | 7.40 M | 7.27 M | 8.38 M | 7.94 M | 8.18 M | 9.33 M | 9.08 M | ||||||||||
| Consensus Estimate | 7.04 M | 8.28 M | 8.69 M | 10.06 M | 7.12 M | 8.68 M | 7.73 M | 6.31 M | 6.90 M | 7.94 M | 7.57 M | 9.08 M | 8.49 M | 8.76 M | 9.82 M | 9.43 M |
Analysts expect Maxcyte, Inc. to report earnings per share of -0.08 for Q3 26, against a range of -0.09 to -0.07. The most recent reported quarter, Q2 26, came in at -0.08, a 11.1% beat against the -0.09 consensus.
| Metric | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 | Q1 30 | Q2 30 | Q3 30 | Q4 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | -0.11 | -0.10 | -0.10 | -0.12 | -0.12 | -0.09 | -0.04 | -0.08 | - | - | - | - | - | - | - | - | ||||||||||
| High Estimate | -0.12 | -0.12 | -0.10 | -0.09 | -0.10 | -0.07 | -0.08 | -0.08 | -0.07 | -0.07 | -0.06 | -0.07 | -0.07 | -0.06 | -0.05 | -0.06 | ||||||||||
| Low Estimate | -0.14 | -0.14 | -0.12 | -0.11 | -0.12 | -0.09 | -0.10 | -0.10 | -0.09 | -0.07 | -0.08 | -0.07 | -0.07 | -0.06 | -0.05 | -0.08 | ||||||||||
| Consensus Estimate | -0.13 | -0.13 | -0.11 | -0.10 | -0.11 | -0.08 | -0.09 | -0.09 | -0.08 | -0.07 | -0.07 | -0.07 | -0.07 | -0.06 | -0.05 | -0.07 |
Pull Wall Street consensus for Maxcyte, Inc. (high, low and consensus estimates alongside reported actuals) into your own models and apps with the Business Quant Estimates API. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/estimates?ticker=MXCT&mode=revenue&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/estimates"
params = {"ticker": "MXCT", "mode": "revenue", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/estimates?ticker=MXCT&mode=revenue&api_key=YOUR_API_KEY");
const data = await res.json();